Drug recall · October 8, 2014
DOPamine Hydrochloride and 5% Dextrose INJ recall
Why: Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the overpouch.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, Baxter USA, NDC 0338-1005-02.
- Lots / codes
Lot# P303172; Exp. 12/14
- Quantity
- 11,808 bags
- Company
- Baxter Healthcare Corp., Deerfield, IL
- Distribution
- Nationwide and Canada
- Initiated
- September 29, 2014 · Voluntary: Firm initiated
- Classified
- October 2, 2014
- Reported
- October 8, 2014
- Ended
- September 30, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dopamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.